Leerink Partners
The Equity Research Associate – Oncology role involves analyzing preclinical, translational, and clinical oncology datasets to support investment recommendations and research reports for publicly traded biotechnology companies. The position requires building financial models, monitoring clinical trials and regulatory updates, and engaging with industry experts to evaluate scientific and commercial factors. This role is ideal for candidates with sell-side equity research or related biotechnology experience who can independently drive research and analysis.
Headquarters
Boston, Massachusetts, United States
Company Size
201-500 employees
Founded
1995
Leerink Partners is an investment bank uniquely dedicated to serving innovation-driven and growth-minded healthcare companies.
Leerink Partners Adds Timothy Michel to Trading and Execution Team
Nov 18, 2025
Leerink questions whether BioNTech can thrive without their 'founders' insight' as stock drops
3 days ago
Leerink Partners reiterates Ardelyx stock rating on pipeline progress
21 hours ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Leerink Partners.
He was on the brink amid SVB’s collapse. Now, Jeff Leerink’s firm leads the pack in health care deals.
2 weeks ago
Associate Director, Field Medical Affairs-Thoracic Oncology (GA, FL, TN, AL, MS)
Regeneron Pharmaceuticals
Intern, Translational Sciences
Revolution Medicines
Clinical Research Physician
Translational Research in Oncology
GRAD INTERN Medical Department - ONCOLOGY
Amgen
Equity Investment Analyst
Maritime Financial Group
Clinical Research Medical Director - Oncology
lifelancer